• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

TrovaGene Inc

+ Add to Watchlist

TROV:US

5.4200 USD 0.1400 2.65%

As of 14:07:06 ET on 09/17/2014.

Snapshot for TrovaGene Inc (TROV)

Open: 5.2500 Day's Range: 5.2000 - 5.5000 Volume: 70,743
Previous Close: 5.2800 52wk Range: 2.9700 - 8.5000 1-Yr Rtn: -25.55%

Stock Chart for TROV

No chart data available.
  • TROV:US 5.4200
  • 1D
  • 1M
  • 1Y
5.2800
Interactive TROV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TROV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6692
Est. EPS (USD) (12/2014) -0.7800
Est. PEG Ratio -
Market Cap (M USD) 100.18
Shares Outstanding (M) 18.90
30 Day Average Volume 271,534
Price/Book (mrq) 6.1942
Price/Sale (ttm) 398.6142
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TROV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TROV

TrovaGene, Inc. is an applied genomics company. The Company is developing a non-invasive testing technology using transrenal nucleic acid (TrNA) markers for infectious diseases, prenatal testing, early detection of cancer, and monitoring of organ and cell transplantation.

Antonius P Schuh "Tony"Chief Executive OfficerStephen L Zaniboni "Steve"Chief Financial Officer
Mark ErlanderChief Scientific Officer
More Company Profile & Key Executives for TROV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil